Overview

• Queen Letizia visited the Centro de Investigación del Cáncer and called for equitable, stable financing with investment in research, technology, services, talent and prevention.
• AECC highlighted a new Patient Advocacy program that brings patients into the evaluation, selection and follow-up of projects, with more than 30 participants from 10 provinces.
• Fundación Alivia reported an average 616‑day wait from European authorization to funded access for new oncology drugs in Spain, compared with about 128 days in Germany.
• AECC said it allocates 18% of its income to research and supports a national network of 2,300 researchers across 146 centers working on more than 750 projects.
• Salamanca’s CIC marked 25 years as an international reference center, reporting €160 million in funding, over 2,000 publications, participation in more than 1,000 clinical trials, and multiple patents and spin-offs, with 21 AECC-backed grants in the province nearing €8 million.